Research progress of targeting on Nrf2/ARE pathway in the treatment of ischemic stroke

YANG Xiaofei, LI Qiang, LI Yanfeng, WANG Hongquan

doi:10.16352/j.issn.1001-6325.2023.01.0169

Jichu yixue yu linchuang (Jan 2023)

Research progress of targeting on Nrf2/ARE pathway in the treatment of ischemic stroke

YANG Xiaofei, LI Qiang, LI Yanfeng, WANG Hongquan

Affiliations

YANG Xiaofei, LI Qiang, LI Yanfeng, WANG Hongquan: 1. Department of Neurology, the Affiliated Hospital of Chifeng University, Chifeng 024005;;2. Department of Neurology, Peking Union Medical College Hospital, CAMS & PUMC, Beijing 100050;;3. Department of Neurology, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing 100049, China

DOI: https://doi.org/10.16352/j.issn.1001-6325.2023.01.0169
Journal volume & issue: Vol. 43, no. 1
pp. 169 – 173

Abstract

Read online

Recently, mounting evidences have suggested the therapeutic potential of Nrf2/ARE activators for treating Ischemic stroke. Moreover, several Nrf2 activators attenuate ischemic stroke-induced brain injury in several transient focal cerebral ischemia (tMCAO) in experimental animal models.

ischemic stroke|nf-e2-related factor 2(nrf2)|natural compounds|transient focal cerebral ischemia

Published in Jichu yixue yu linchuang

ISSN: 1001-6325 (Print)
Publisher: Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
Country of publisher: China
LCC subjects: Medicine
Website: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/1001-6325/home.shtml

About the journal

Abstract

Keywords